SCHEMBL20052073

SCHEMBL20052073

CC(C)[C@@H](C)OC(=O)NCCO

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.46
CHRNB4 P30926 2/20 0.46
CHRNA3 P32297 2/20 0.46
CHRNA4 P43681 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
ACHE P22303 8/20 0.36
RAB9A P51151 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
CNR1 P21554 1/20 0.33
EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18591656 1.00 CHRNB2 (0.46) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL606535 0.83 CHRNB2 (0.49) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL19171150 0.83 CTSK (0.31) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL20354392 0.80 CHRNB2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL29045709 0.80 CHRNB2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL9639334 0.79 CHRNB2 (0.46) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL12233187 0.78 CHRNB2 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL10874284 0.78 CHRNB2 (0.45) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL11233858 0.77 EPHX1 (0.61) ACHEEPHX1
SCHEMBL19234898 0.77 PGK1 (0.40) ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944654-B2 Nargenicin compounds and uses thereof as antibacterial agents MERCK SHARP & DOHME CORP. (US) 2018-04-17 US disclosed